Summary
PpSC and its forthcoming product: Platelet-rich plasma Kit® (TPRPK) is being developed to exploit the massive potential for painless & cost efficient procedures available to patients with various skin conditions and global Facial rejuvenation sector. The key innovations with TPRPK platform are increased lifespan of platelet-rich plasma and none invasive topical application instead of multiple painful injections. In addi-tion, the IP protected PRP storage device and how one feeds into the other. PpSC will initially focus on healing and rejuvenation of the injured tissues along with a calculation of resources reductions achieved through the process. It is envisaged that the PpSC will scale its TPRPK operations across healthcare and cosmetic sectors worldwide in due course.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/827957 |
| Start date: | 01-09-2018 |
| End date: | 28-02-2019 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
PpSC and its forthcoming product: Platelet-rich plasma Kit® (TPRPK) is being developed to exploit the massive potential for painless & cost efficient procedures available to patients with various skin conditions and global Facial rejuvenation sector. The key innovations with TPRPK platform are increased lifespan of platelet-rich plasma and none invasive topical application instead of multiple painful injections. In addi-tion, the IP protected PRP storage device and how one feeds into the other. PpSC will initially focus on healing and rejuvenation of the injured tissues along with a calculation of resources reductions achieved through the process. It is envisaged that the PpSC will scale its TPRPK operations across healthcare and cosmetic sectors worldwide in due course.Status
CLOSEDCall topic
EIC-SMEInst-2018-2020Update Date
27-10-2022
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
